Skip to main content
Erschienen in: Obesity Surgery 4/2015

01.04.2015 | Original Contributions

Primary Hyperparathyroidism After Roux-en-Y Gastric Bypass

verfasst von: Yufei Chen, Carrie C. Lubitz, Scott A. Shikora, Richard A. Hodin, Randall D. Gaz, Francis D. Moore Jr, Travis J. McKenzie

Erschienen in: Obesity Surgery | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary hyperparathyroidism (PHPT) in the setting of previous roux-en-Y gastric bypass (RYGBP) is not well described. The diagnosis can be difficult, as secondary hyperparathyroidism (SHPT) commonly occurs in patients after RYGBP due to calcium malabsorption and vitamin D deficiency.

Methods

All patients from 2000 to 2012 who underwent cervical exploration for diagnosis of primary hyperparathyroidism with history of preceding RYGBP were identified and analyzed retrospectively.

Results

Ten patients were identified. The average age was 58.4 and all patients were female. Time interval between RYGBP and cervical exploration was 67 months with median follow-up of 19 months. Average preoperative calcium was 10.8 mg/dL, PTH 155 pg/mL, and 25-vitamin-D 32 ng/mL. Eighty percent of patients presented with symptoms and 90 % underwent preoperative imaging. Seventy percent underwent initial focused parathyroidectomy with 20 % being converted to four-gland exploration. Seventy percent of patients had a single adenoma with two patients having multi-gland disease. Intraoperative PTH was used in seven patients with successful drop to 50 % of baseline in all. Ninety percent of patients had greater then 6-month follow-up without evidence of persistent or recurrent PHPT. Average 6-month calcium was 9.3 mg/dL, PTH 73 pg/mL, and 25-vitamin-D 44 ng/ML. Four patients had evidence of persistently elevated PTH despite normalization of calcium.

Conclusions

PHPT after RYGBP is rare but surgery with either a focused approach following successful localization or four-gland exploration is indicated when the biochemical diagnosis holds true. The presence of SHPT can make diagnosis and follow-up difficult and may predispose them to severe post-operative hypocalcemia.
Literatur
1.
Zurück zum Zitat Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–102. eng.CrossRefPubMed Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–102. eng.CrossRefPubMed
2.
Zurück zum Zitat Nguyen NT, Masoomi H, Magno CP, et al. Trends in use of bariatric surgery, 2003–2008. J Am Coll Surg. 2011;213:261–6. eng.CrossRefPubMed Nguyen NT, Masoomi H, Magno CP, et al. Trends in use of bariatric surgery, 2003–2008. J Am Coll Surg. 2011;213:261–6. eng.CrossRefPubMed
3.
Zurück zum Zitat Jin J, Robinson AV, Hallowell PT, et al. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature. Surgery. 2007;142:914–20. discussion 914–20. eng.CrossRefPubMed Jin J, Robinson AV, Hallowell PT, et al. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature. Surgery. 2007;142:914–20. discussion 914–20. eng.CrossRefPubMed
4.
Zurück zum Zitat Avgerinos DV, Leitman IM, Martínez RE, et al. Evaluation of markers for calcium homeostasis in a population of obese adults undergoing gastric bypass operations. J Am Coll Surg. 2007;205:294–7. eng.CrossRefPubMed Avgerinos DV, Leitman IM, Martínez RE, et al. Evaluation of markers for calcium homeostasis in a population of obese adults undergoing gastric bypass operations. J Am Coll Surg. 2007;205:294–7. eng.CrossRefPubMed
5.
Zurück zum Zitat Johnson JM, Maher JW, DeMaria EJ, et al. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006;243:701–4. discussion 704–5. eng.CrossRefPubMedCentralPubMed Johnson JM, Maher JW, DeMaria EJ, et al. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006;243:701–4. discussion 704–5. eng.CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Carlin AM, Rao DS, Yager KM, et al. Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis. 2006;2:638–42. eng.CrossRefPubMed Carlin AM, Rao DS, Yager KM, et al. Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis. 2006;2:638–42. eng.CrossRefPubMed
7.
Zurück zum Zitat Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005;9:1106–10. discussion 1110–1. eng.CrossRefPubMed Johnson JM, Maher JW, Samuel I, et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005;9:1106–10. discussion 1110–1. eng.CrossRefPubMed
8.
Zurück zum Zitat Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol. 2010;45:133–8. eng.CrossRefPubMed Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol. 2010;45:133–8. eng.CrossRefPubMed
9.
Zurück zum Zitat Malone M, Alger-Mayer SA. Medication use patterns after gastric bypass surgery for weight management. Ann Pharmacother. 2005;39:637–42. eng.CrossRefPubMed Malone M, Alger-Mayer SA. Medication use patterns after gastric bypass surgery for weight management. Ann Pharmacother. 2005;39:637–42. eng.CrossRefPubMed
10.
Zurück zum Zitat Crowley LV, Seay J, Mullin G. Late effects of gastric bypass for obesity. Am J Gastroenterol. 1984;79:850–60. eng.PubMed Crowley LV, Seay J, Mullin G. Late effects of gastric bypass for obesity. Am J Gastroenterol. 1984;79:850–60. eng.PubMed
11.
Zurück zum Zitat Grant CS, Thompson G, Farley D, et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–8. discussion 478–9. eng.CrossRefPubMed Grant CS, Thompson G, Farley D, et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–8. discussion 478–9. eng.CrossRefPubMed
12.
Zurück zum Zitat Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9. eng.CrossRefPubMedCentralPubMed Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9. eng.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin N Am. 2004;37:701–13. vii-viii. eng.CrossRef Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin N Am. 2004;37:701–13. vii-viii. eng.CrossRef
14.
Zurück zum Zitat Corlew DS, Bryda SL, Bradley EL, et al. Observations on the course of untreated primary hyperparathyroidism. Surgery. 1985;98:1064–71. eng.PubMed Corlew DS, Bryda SL, Bradley EL, et al. Observations on the course of untreated primary hyperparathyroidism. Surgery. 1985;98:1064–71. eng.PubMed
15.
Zurück zum Zitat Nilsson I, Yin L, Lundgren E, et al. Clinical presentation of primary hyperparathyroidism in Europe—nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res. 2002;17(2):N68–74. eng.PubMed Nilsson I, Yin L, Lundgren E, et al. Clinical presentation of primary hyperparathyroidism in Europe—nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res. 2002;17(2):N68–74. eng.PubMed
16.
Zurück zum Zitat Allendorf J, DiGorgi M, Spanknebel K, et al. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80. eng.CrossRefPubMed Allendorf J, DiGorgi M, Spanknebel K, et al. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80. eng.CrossRefPubMed
17.
Zurück zum Zitat Lee NC, Norton JA. Multiple-gland disease in primary hyperparathyroidism: a function of operative approach? Arch Surg. 2002;137:896–9. discussion 899–900. eng.CrossRefPubMed Lee NC, Norton JA. Multiple-gland disease in primary hyperparathyroidism: a function of operative approach? Arch Surg. 2002;137:896–9. discussion 899–900. eng.CrossRefPubMed
18.
Zurück zum Zitat Singer MC, Pucar D, Mathew M, et al. Improved localization of sestamibi imaging at high-volume centers. Laryngoscope. 2013;123:298–301. eng.CrossRefPubMed Singer MC, Pucar D, Mathew M, et al. Improved localization of sestamibi imaging at high-volume centers. Laryngoscope. 2013;123:298–301. eng.CrossRefPubMed
19.
Zurück zum Zitat Adkisson CD, Koonce SL, Heckman MG, et al. Predictors of accuracy in preoperative parathyroid adenoma localization using ultrasound and Tc-99m-sestamibi: a 4-quadrant analysis. Am J Otolaryngol. 2013;34:508–16. eng.CrossRefPubMed Adkisson CD, Koonce SL, Heckman MG, et al. Predictors of accuracy in preoperative parathyroid adenoma localization using ultrasound and Tc-99m-sestamibi: a 4-quadrant analysis. Am J Otolaryngol. 2013;34:508–16. eng.CrossRefPubMed
20.
Zurück zum Zitat Garner SC, Leight GS. Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism. Surgery. 1999;126:1132–7. discussion 1137–8. eng.CrossRefPubMed Garner SC, Leight GS. Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism. Surgery. 1999;126:1132–7. discussion 1137–8. eng.CrossRefPubMed
21.
Zurück zum Zitat Lupoli GA, Fonderico F, Panico A, et al. Stricter criteria increase the validity of a quick intraoperative parathyroid hormone assay in primary hyperparathyroidism. Med Sci Monit. 2009;15:CR111–6. eng.PubMed Lupoli GA, Fonderico F, Panico A, et al. Stricter criteria increase the validity of a quick intraoperative parathyroid hormone assay in primary hyperparathyroidism. Med Sci Monit. 2009;15:CR111–6. eng.PubMed
22.
Zurück zum Zitat Reiher AE, Schaefer S, Chen H, et al. Does the final intraoperative PTH level really have to fall into the normal range to signify cure? Ann Surg Oncol. 2012;19:1862–7. eng.CrossRefPubMed Reiher AE, Schaefer S, Chen H, et al. Does the final intraoperative PTH level really have to fall into the normal range to signify cure? Ann Surg Oncol. 2012;19:1862–7. eng.CrossRefPubMed
23.
Zurück zum Zitat McKenzie TJ, Chen Y, Hodin RA, et al. Recalcitrant hypocalcemia after thyroidectomy in patients with previous Roux-en-Y gastric bypass. Surgery. 2013;154:1300–6. discussion 1306. eng.CrossRefPubMedCentralPubMed McKenzie TJ, Chen Y, Hodin RA, et al. Recalcitrant hypocalcemia after thyroidectomy in patients with previous Roux-en-Y gastric bypass. Surgery. 2013;154:1300–6. discussion 1306. eng.CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Witteveen JE, van Thiel S, Romijn JA, et al. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168:45–53. eng.CrossRef Witteveen JE, van Thiel S, Romijn JA, et al. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168:45–53. eng.CrossRef
25.
Zurück zum Zitat Mittendorf EA, Merlino JI, McHenry CR. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg. 2004;70:114–9. discussion 119–20. eng.PubMed Mittendorf EA, Merlino JI, McHenry CR. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg. 2004;70:114–9. discussion 119–20. eng.PubMed
26.
Zurück zum Zitat Palal B, Sinsakul M, Reutrakul S. Life-threatening hypocalcemia following subtotal parathyroidectomy in a patient with renal failure and previous Roux-en-Y gastric bypass surgery. Case Rep Endocrinol 2011;2011:370583. eng. Palal B, Sinsakul M, Reutrakul S. Life-threatening hypocalcemia following subtotal parathyroidectomy in a patient with renal failure and previous Roux-en-Y gastric bypass surgery. Case Rep Endocrinol 2011;2011:370583. eng.
Metadaten
Titel
Primary Hyperparathyroidism After Roux-en-Y Gastric Bypass
verfasst von
Yufei Chen
Carrie C. Lubitz
Scott A. Shikora
Richard A. Hodin
Randall D. Gaz
Francis D. Moore Jr
Travis J. McKenzie
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 4/2015
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1444-2

Weitere Artikel der Ausgabe 4/2015

Obesity Surgery 4/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.